Rifaximin-EIR Tablet

rifaximin · Alfasigma S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rifaximin-EIR Tablet, covering 2010-02-22 to 2010-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease [Phase 2]